Literature DB >> 16696805

Treatment of haemorrhagic radiation-induced proctopathy using small volume topical formalin instillation.

S N Cullen1, M Frenz, A Mee.   

Abstract

BACKGROUND: Between 2 and 5% of patients undergoing pelvic radiotherapy develop chronic radiation proctopathy, occurring as a result of damage to the rectal mucosa during the treatment. Rectal bleeding of varying severity can occur as a consequence. There have been no formal trials of treatment for haemorrhagic radiation proctopathy and a variety of methods are currently used. AIM: In a retrospective study of 20 patients treated at a single centre, we assessed the efficacy of small volume topical formalin instillation to control bleeding from radiation proctopathy.
METHOD: Patients were treated by a single operator using 20 mL of a 5% solution of formalin instilled into the rectum via a flexible sigmoidoscope for 3 min. Patients were followed up for an average of 22.7 months (range: 2-69).
RESULTS: A single session of formalin treatment was effective in 13 of 20 (65%) patients and a further four (20%) patients responded to a second treatment. No complications of the treatment was identified.
CONCLUSION: Small volume formalin instillation therapy appears to be safe and effective in the context of haemorrhagic radiation proctopathy. The technique is simple, inexpensive, quick and requires no sedation. We suggest that it should be considered as a first line for patients presenting with this distressing condition.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16696805     DOI: 10.1111/j.1365-2036.2006.02920.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  8 in total

Review 1.  Chronic radiation proctopathy: A practical review of endoscopic treatment.

Authors:  Luciano Lenz; Rachel Rohr; Frank Nakao; Ermelindo Libera; Angelo Ferrari
Journal:  World J Gastrointest Surg       Date:  2016-02-27

Review 2.  Managing gastrointestinal symptoms after cancer treatment: a practical approach for gastroenterologists.

Authors:  Ann C Muls; Lorraine Watson; Clare Shaw; H Jervoise N Andreyev
Journal:  Frontline Gastroenterol       Date:  2012-10-02

3.  A mechanism for abnormal angiogenesis in human radiation proctitis: analysis of expression profile for angiogenic factors.

Authors:  Hisashi Takeuchi; Tetsuo Kimura; Koichi Okamoto; Eriko Aoyagi; Hiroshi Miyamoto; Masako Kaji; Hidetaka Takenaka; Seisuke Okamura; Yasushi Sato; Junji Kato; Toshiya Okahisa; Tetsuji Takayama
Journal:  J Gastroenterol       Date:  2011-11-15       Impact factor: 7.527

4.  Approaches to the prevention and management of radiation colitis.

Authors:  Mohammed A Qadeer; John J Vargo
Journal:  Curr Gastroenterol Rep       Date:  2008-10

5.  Treatment of hemorrhagic radiation-induced proctopathy with a 4% formalin application under perianal anesthetic infiltration.

Authors:  Narimantas Evaldas Samalavicius; Audrius Dulskas; Alfredas Kilius; Kestutis Petrulis; Darius Norkus; Arvydas Burneckis; Konstantinas Povilas Valuckas
Journal:  World J Gastroenterol       Date:  2013-08-14       Impact factor: 5.742

6.  Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer.

Authors:  H Jervoise N Andreyev; Susan E Davidson; Catherine Gillespie; William H Allum; Edwin Swarbrick
Journal:  Gut       Date:  2011-11-04       Impact factor: 23.059

7.  Guidance: The practical management of the gastrointestinal symptoms of pelvic radiation disease.

Authors:  H Jervoise N Andreyev; Ann C Muls; Christine Norton; Charlotte Ralph; Lorraine Watson; Clare Shaw; James O Lindsay
Journal:  Frontline Gastroenterol       Date:  2014-06-17

8.  Diverting colostomy is an effective and reversible option for severe hemorrhagic radiation proctopathy.

Authors:  Zi-Xu Yuan; Qi-Yuan Qin; Miao-Miao Zhu; Qing-Hua Zhong; Alessandro Fichera; Hui Wang; Huai-Ming Wang; Xiao-Yan Huang; Wu-Teng Cao; Ye-Biao Zhao; Lei Wang; Teng-Hui Ma
Journal:  World J Gastroenterol       Date:  2020-02-28       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.